Home/Filings/4/0001209191-15-067841
4//SEC Filing

BIOCEPT INC 4

Accession 0001209191-15-067841

CIK 0001044378operating

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 5:33 PM ET

Size

7.2 KB

Accession

0001209191-15-067841

Insider Transaction Report

Form 4
Period: 2015-08-24
ARNOLD LYLE J
SVP, Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2015-08-2410,7140 total
    Exp: 2015-08-24Common Stock (10,714 underlying)
  • Exercise/Conversion

    Common Stock

    2015-08-24+10,71410,714 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units are fully vested. Pursuant to the terms of the restricted stock unit agreement entered into with the reporting person, settlement of the vested restricted stock units takes place on the earliest to occur of (a) August 24, 2015 or (b) other triggering events identified in the restricted stock unit agreement.

Issuer

BIOCEPT INC

CIK 0001044378

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001044378

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:33 PM ET
Size
7.2 KB